<DOC>
	<DOC>NCT01948765</DOC>
	<brief_summary>The investigators hypothesize that the application of 30% xenon as an adjuvant to general anesthesia with a target-controlled infusion of propofol is superior to general anesthesia with propofol alone with respect to hemodynamic stability.</brief_summary>
	<brief_title>Xenon as an Adjuvant to Propofol Anaesthesia in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery.</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Xenon</mesh_term>
	<criteria>patients with coronary artery disease scheduled for elective OPCABsurgery patients willing and able to complete the requirements of this study Ejection fraction &gt;30% Lack of informed consent age &lt; 18 years COPD GOLD &gt;II Renal dysfunction defined as serumcreatinine &gt;1.5mg/dl acute coronary syndrome during the last 24 hours; haemodynamic instability, requirement of inotropic support single vessel grafting disabling neuropsychiatric disorders (severe dementia, Alzheimer's disease, schizophrenia, depression, low preoperative cognitive state (MMSE at baseline &lt;25), history of stroke with residuals, increased intracranial pressure Hypersensitivity to the study medication Presumed uncooperativeness or legal incapacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>xenon anesthesia</keyword>
	<keyword>Off-pump coronary artery bypass graft surgery</keyword>
</DOC>